Martin Shkreli, the Turing Pharmaceuticals CEO that recently made headlines for spending $2 million for Wu-Tang Clan’s one-of-a-kind Once Upon A Time In Shaolin, has been arrested on charges of securities fraud.
Shkreli first made the rounds earlier this year, when he raised the price of an AIDS medication from $13.50 to $750. Incidentally, neither the Wu-Tang album or the price gouging were the cause of his downfall.
It seems that Shkreli also started the firm Retrophin, Inc., a biotechnology research company. By taking stock from Retrophin and using it to pay unrelated business debts, Shkreli had broken the law. The company’s board ousted him and filed a lawsuit against him, and has since cooperated with federal investigations.
Even Donald Trump called him a “spoiled brat,” and Bernie Sanders rerouted a $2,700 donation to an HIV clinic in lieu of accepting it for his campaign. The guys from Wu-Tang Clan took his money and donated it to charity as well.
Seems like Shkreli won’t be getting that private Radiohead album anytime soon.